New 52 Week Low Today

Healios KK 4593.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 2:20 PM JST
397.00quote price arrow down-18.00 (-4.34%)
Volume
4,076,300
52 week range
391.00 - 2,557.00
Loading...
  • Open428.00
  • Day High432.00
  • Day Low391.00
  • Prev Close415.00
  • 52 Week High2,557.00
  • 52 Week High Date09/07/21
  • 52 Week Low391.00
  • 52 Week Low Date05/26/22

Key Stats

  • Market Cap341.97M
  • Shares Out55.15M
  • 10 Day Average Volume2.17M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-69.06

KEY STATS

  • Open428.00
  • Day High432.00
  • Day Low391.00
  • Prev Close415.00
  • 52 Week High2,557.00
  • 52 Week High Date09/07/21
  • 52 Week Low391.00
  • 52 Week Low Date05/26/22
  • Market Cap341.97M
  • Shares Out55.15M
  • 10 Day Average Volume2.17M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-69.06

RATIOS/PROFITABILITY

  • EPS (TTM)-90.70
  • P/E (TTM)-4.38
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Healios KK

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
HEALIOS K.K. is a Japan-based company mainly engaged in research and development of pharmaceutical products. The Company has compound pharmaceutical products line and induced pluripotent stem cell (iPSC) regenerative medicine product line. The compound pharmaceutical product line contains HLM0021, HLM0022 and HLM0023. The products are ophthalmological surgery adjuvants, mainly contain brilliant blue G-250 (BBG250) which help capsule temporarily safely stained to protect the...
Tadahisa Kagimoto M.D.
President, Chief Executive Officer, Representative Executive Officer, Director
Richard Kincaid
Chief Financial Officer, Executive Officer, President of Subsidiary, Director
Masanori Sawada M.D., Ph.D., MBA
Executive Vice President, Chief Medical Officer
Address
11F, Seiroka Tower, 8-1, Akashi-cho
Chiyoda-ku, TKY
100-0006
Japan